[display_name_for_the_car_t_direc_705]

Location Info

University Hospitals Seidman Cancer Center
11100 Euclid Ave,
Cleveland, OH 44106
Phone number: (216) 844-5432

Background data

Program type: Adult Program
FACT Approved: Yes
Year CAR T-cell Therapy Program Opened: 2018

CAR T-cell therapies performed

Year 2020 2021 2022 2023
Number Performed 23 21 28 34

Program Director

Name Phone
Koen van Besien, MD, PhD (216) 844-0139

Medical Director

Name Phone
Koen van Besien, MD, PhD (216) 844-0139

Physician

Name Phone
Ok-Kyong Chaekal, MD (216) 844-0139
Brenda Cooper, MD (216) 844-3213
Changchun Deng, MD, PhD (216) 844-0139
Molly Gallogly, MD, PhD (216) 844-0139
Rebecca Klisovic, MD (216) 844-3951
Leland Metheny, MD (216) 983-4753
Benjamin Tomlinson, MD (216) 286-9185
Koen van Besien, MD, PhD (216) 844-0139

Coordinator

Name Phone
Nancy Buchta, RN (216) 844-8657
Merle Kolk, MPH (216) 844-8473
Nicole Piascik, RN, BSN (216) 844-3614
Michelle Powichrowski, RN, BSN (216) 844-5830
Adrian Simpson, BS, CHAA (216) 844-5830
Olivia Sir Louis, RN, BSN (216) 844-3659

Social Worker

Name Phone
Amy Eliason, MSSA, LISW-S (216) 286-6397
Pamela Gleisser, MSW, LISW (216) 286-7079
Janelle Haney, MSSA, LISW (216) 286-3815
Kelli Masi, LSW
Andrea Moskowitz, MSW, LISW (216) 286-3017

Diseases treated by CAR T-cell therapy

  • Leukemia, acute lymphoblastic
  • Lymphoma
  • Mantle Cell Lymphoma
  • Multiple Myeloma

CAR T-Cell products

  • Abecma (idecabtagene vicleucil, ide-cel)
  • Breyanzi (lisocabtagene maraleucel, liso-cel)
  • Kymriah (tisagenlecleucel, tisa-cel)
  • Tecartus (brexucabtagene autoleucel, brexu-cel)
  • Yescarta (axicabtagene ciloleucel, axi-cel)